4//SEC Filing
Onaitis Matthew 4
Accession 0001209191-12-053988
CIK 0001339455other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 1:59 PM ET
Size
5.6 KB
Accession
0001209191-12-053988
Insider Transaction Report
Form 4
Onaitis Matthew
VP, General Counsel
Transactions
- Award
Common Stock
2012-11-16+30,000→ 57,093 total
Footnotes (1)
- [F1]Subject to the terms of the Restricted Stock Unit Agreement, 50% of the RSU Award shall vest upon the first date included within an open trading window under the Company's Insider Trading Policy following December 31, 2014 and 50% of the RSU Award shall vest upon the first date included within an open trading window under the Company's Insider Trading Policy following December 31, 2015, subject to Participant's continued status as an Employee, Independent Director or Consultant (each as defined in the 2005 Equity Incentive Award Plan (the "Plan")) of the Company or any Subsidiary on such vesting date. Notwithstanding anything to the contrary in the Plan, in the event of a Change in Control (as defined in the Plan) prior to the vesting date as set forth above, 100% of the unvested RSUs will vest upon the consummation of the Change in Control.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001362822
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 1:59 PM ET
- Size
- 5.6 KB